Influenza Vaccination at a Reduced Dose Using Mesotherapy in HIV/AIDS Patients at the Hadassah AIDS Center, Jerusalem
|ClinicalTrials.gov Identifier: NCT00758212|
Recruitment Status : Unknown
Verified September 2008 by Hadassah Medical Organization.
Recruitment status was: Enrolling by invitation
First Posted : September 25, 2008
Last Update Posted : October 9, 2008
|Condition or disease||Intervention/treatment|
|Influenza Acquired Immune Deficiency Syndrome HIV Infections||Biological: Mesotherapy|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Influenza Vaccination at a Reduced Dose of 1:10 Using Mesotherapy in HIV/AIDS Patients at the Hadassah AIDS Center, Jerusalem|
|Study Start Date :||November 2008|
|Estimated Primary Completion Date :||January 2009|
|Estimated Study Completion Date :||April 2009|
The experimental group will consist of HIV/AIDS patients(approx.50) who volunteer to receive a reduced dose Influenza vaccine using mesotherapy as a mode of injecting the vaccine intradermally.
The regular seasonal trivalent Influenza vaccine( Vaxigrip) will be diluted 1:10 in saline.The diluted vaccine will be given intra-dermally using Mesotherapy,namely multiple injections given at one time in the torso, back and axillae.
Other Name: Vaxigrip Trivalent Influenza vaccine , diluted 1:10.
- anti influenza antibody using Hemagglutination inhibition [ Time Frame: 1 , 3 , 6 months ]
- acceptability of influenza vaccination using mesotherapy [ Time Frame: 1month ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00758212
|Hadassah U. hospital|
|Principal Investigator:||shlomo maayan, md||Hadassah Medical Organization|